Hanson Wade light-logo dark-logo-new
Conference

5th Targeted Radiopharmaceuticals Summit EU

December 2023
Advancing Radioligand Candidates to Commercialisation
ADCs & Engineered Antibodies
Conference

3rd ADC Target Selection Summit

December 2023
Optimizing Target Selection Rationale for ADCs & Novel Format Conjugates
ADCs & Engineered Antibodies
Conference

3rd Next-Generation Conjugates Summit

February 2024
Progressing the Future of Bioconjugates from Bench to Bedside
ADCs & Engineered Antibodies
Conference

14th World ADC London

March 2024
Maximising the Therapeutic Window of ADCs
ADCs & Engineered Antibodies
Conference

3rd ADC Analytical Development Summit

April 2024
Ensuring Your ADC's Product Quality, Identity & Potency
ADCs & Engineered Antibodies
Conference

6th Cell Engager Therapeutics Summit

May 2024
Develop Novel, Safe & Effective Multi-Specific Immune Cell Engagers
ADCs & Engineered Antibodies
Conference

5th Cytokine-Based Drug Development Summit

May 2024
Advancing Safe & Durable 2nd Generation Cytokine Therapies into the Clinic
ADCs & Engineered Antibodies
Conference

4th Tumor Myeloid Targeting Therapies Summit

June 2024
Forging New Treatment Pathways by Harnessing the Myeloid Compartment
ADCs & Engineered Antibodies
Conference

2nd ADC Toxicity Summit

July 2024
Minimizing Toxicities & Improving Tolerability to Maximize the TI of ADCs
ADCs & Engineered Antibodies
Conference

5th STING & TLR-Targeted Therapies Summit

July 2024
Advancing the Next Wave of Immunotherapeutics: STING, TLR & Others
ADCs & Engineered Antibodies
Conference

3rd Targeted Radiopharmaceuticals Summit US

July 2024
Attain Clinical Efficacy of Your TRP Pipeline through Next Generation Targets
ADCs & Engineered Antibodies
Conference

2nd ADC Linker & Conjugation Summit

August 2024
Optimize Your ADCs Chemistry to Improve Efficacy, Stability, and Reduce Off-Target Toxicities
ADCs & Engineered Antibodies
Conference

2nd TRP Manufacturing & Supply Chain Summit

September 2024
Optimizing Radioisotope Production & Supply to Support Complex Radiopharmaceutical Manufacturing Processes
ADCs & Engineered Antibodies
Conference

ADC Process Development Summit

September 2024
Accelerate to First-In-Human Studies & Validate Robust Commercial Preparedness
ADCs & Engineered Antibodies
Conference

15th World Bispecifics Summit

September 2024
Radically Transform Bi-& Multispecific Target Selection, Mechanistic Diversity, Clinical Translation & Manufacturing Success
ADCs & Engineered Antibodies
Conference

4th TGF-B for Immuno-Oncology Drug Development

October 2024
Unlocking TGF-B to Advance Safe & Efficacious Immuno-Oncology Therapeutics
ADCs & Engineered Antibodies
Conference

15th World ADC San Diego Summit

November 2024
The World’s Largest, Most Comprehensive & Definitive Antibody-Drug Conjugate Event
ADCs & Engineered Antibodies

View and search all of our conferences.

ConferencesView All Conferences

Maximizing the Therapeutic Window of ADCs & Engineered Antibodies

FC World ADC

World ADC Series Sponsorship Prospectus

 

The potential of antibody drug conjugates is enormous.

The World ADC team focuses on the most challenging problems facing the industry, sourcing the leading experts who have innovative solutions and distilling this into accessible information and opportunities.

From market-leading global conferences, to focus groups, to digital webinars and survey platforms, the World ADC Series enables you to benefit from essential insights and connections through our solutions.

Download a copy

Sponsorship Prospectus - Gated Download Form ADC

Testimonials

“The World ADC conference continues to be the premiere, definitive event for all those such as myself working in this field”

Levena Biopharma

“Premier conference to get up to date information on all things ADC – if you can only attend one ADC-related conference, this is the one”

MacroGenics

“It was a perfect event for anyone in the ADC field as it provided a great opportunity to learn about the various technologies, advances, and future directions while also being candid about the areas for improvement”

Alamar Biosciences

“Great speakers, great content, great attendees and great location”

AmMax Bio

“It was a great, one-stop shop for all the latest updates in the ADC field”

AstraZeneca

“It was a great, one-stop shop for all the latest updates in the ADC field.”

AstraZeneca

ADCs & Engineered Antibodies Conferences – Product Team

Fiona Mistri, MSc

Group Managing Director

Elayda Hearne, MSc

Portfolio Director

Tom Cosgrove

Brand Director

ADCs & Engineered Antibodies Product Types

Expert-driven, Life Science Market Intelligence Solutions

Explore More

Make Faster, Better Drug Development Decisions

Explore More

Premium Insight, Collaborative Learning & Mission-Focused Connections for Biopharma

Explore More

CONTACT US

Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - ADCs & Engineered Antibodies

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.